Cocaine and nicotine abuse remain serious problems in today's society, and despite new treatments, recidivism rates remain high. While it is generally agreed that the powerful reinforcing and, in the case of cocaine, euphorigenic properties, are principally responsible for maintaining drug-seeking and drug-taking behavior, little is known about the neurobiological mechanisms and sites of action of these agents in the human central nervous system (CNS). Such knowledge appears necessary for the ultimate development of more successful treatment strategies. As such, the overall goal of this project is to define those neuronal systems and circuits mediating nicotine and cocaine actions in the human CNS and to determine which subset of these sites participate in their withdrawal, craving and reinforcing properties. As pharmacological agents, cocaine and nicotine produce a number of profound behavioral and physiological effects. Evidence from animal models support their interaction with the mesocorticolimbic (MCL) dopamine system in producing their reinforcing properties. However, both the role of the MCL system and where and how these drugs act in humans is almost completely unknown as the tools to noninvasively address this question have lacked the necessary sensitivity. Finally, it is recognized that drugs do not exert a simple pharmacological action within CNS. Their powerful stimulant properties become paired with environmental cues to form conditioned responses (CRs) which are thought to be able to promote continued drug use and increase relapse probability. Once again, virtually nothing is known regarding their neuroanatomic substrates. It is hypothesized that these agents activate cortical and subcortical terminal fields of the MCLDA system and that these regions will also be selectively altered during chronic drug use as manifest by alterations in system functioning during drug withdrawal and craving. With the relationship between cerebral electrochemical activity, blood flow and glucose metabolism, functional metabolic mapping of the nervous system is possible using a number of noninvasive techniques in man. Functional magnetic resonance imaging is a very new application of MRI that permits an examination of functional cerebral activity without the use of X-rays or ionizing radiation. Its excellent temporal (seconds) and spatial (2-3 mm) resolution permits virtual 'real time' imaging and within subject designs not possible with other current procedures. This proposal will utilize this novel technique to determine the neuroanatomic sites of action of nicotine and cocaine and the ability of these drugs to alter neuronal responsivity when performing cognitive tasks believed to activate neuronal DA terminal regions. We will also examine the time course of withdrawal and the effects of cue-induced craving on both """"""""resting"""""""" and task-induced neuronal activation. We will also address the question of reinforcement circuitry in the human brain. It is hoped that these data may eventually lead to better understanding of, and strategies for treating drug addiction, producing, in turn, a decrease in recidivism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009465-04
Application #
2517947
Study Section
Special Emphasis Panel (SRCD)
Project Start
1994-09-30
Project End
1999-07-31
Budget Start
1997-09-01
Budget End
1998-07-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Psychiatry
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Amen, Shelley L; Piacentine, Linda B; Ahmad, Muhammad E et al. (2011) Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology 36:871-8
Risinger, Robert C; Salmeron, Betty Jo; Ross, Thomas J et al. (2005) Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26:1097-108
Xi, Zheng-Xiong; Wu, Gaohong; Stein, Elliot A et al. (2004) Opiate tolerance by heroin self-administration: an fMRI study in rat. Magn Reson Med 52:108-14
Knight, David C; Smith, Christine N; Cheng, Dominic T et al. (2004) Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cogn Affect Behav Neurosci 4:317-25
Knight, David C; Cheng, Dominic T; Smith, Christine N et al. (2004) Neural substrates mediating human delay and trace fear conditioning. J Neurosci 24:218-28
Lawrence, Natalia S; Ross, Thomas J; Hoffmann, Ray et al. (2003) Multiple neuronal networks mediate sustained attention. J Cogn Neurosci 15:1028-38
Garavan, H; Ross, T J; Kaufman, J et al. (2003) A midline dissociation between error-processing and response-conflict monitoring. Neuroimage 20:1132-9
Xi, Zheng-Xiong; Stein, Elliot A (2002) GABAergic mechanisms of opiate reinforcement . Alcohol Alcohol 37:485-94
Garavan, H; Ross, T J; Murphy, K et al. (2002) Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage 17:1820-9
Xi, Zheng-Xiong; Stein, Elliot A (2002) Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology (Berl) 164:144-50

Showing the most recent 10 out of 35 publications